Xin Yuyan, the R&D team leader at Tianyang Corporation, gained the recognition of Nuo Yan, President of Nuoyan Group, thanks to her cutting-edge research capabilities. She secured a 3 billion-yuan investment for Tianyang, which was on the brink of bankruptcy. However, she was forced to work overtime throughout her pregnancy. After giving birth, she faced further retaliation including demotion and pay cuts, as the company sought to seize her scientific research achievements. Harassed relentlessly by the firm, she grew disheartened and resigned in anger.
Fortunately, after stepping down, she received support from President Nuo Yan, who had long admired her talent. Through successive commercial confrontations with her former employer, she exposed Tianyang’s acts of research plagiarism and unfair competition. She successfully helped Nuoyan host its new drug launch conference. To express gratitude to Xin Yuyan, Nuoyan promoted her to Group Partner and awarded her a 10% equity stake in the group.
